Lotus Pharmaceutical Company Description

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity.

The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services.

In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization.

Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Lotus Pharmaceutical Co., Ltd.

Country	Taiwan
Founded	1966
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,099
CEO	Petar Vazharov

Contact Details

Address: No. 277 Song Ren Road Taipei, 110 Taiwan
Phone	886 2 2700 5908
Website	lotuspharm.com.tw

Stock Details

Ticker Symbol	1795
Exchange	Taiwan Stock Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0001795003
SIC Code	2834

Key Executives

Name	Position
Petar Antonov Vazharov	Chief Executive Officer
Bjartur Shen	Vice President of Strategies and Finance
Eeling Chan	Chief Financial Officer
Vamsi Kiran Kosaraju	Chief Operations Officer
Gwen Hsieh	Chief Information Officer
Yu-Ying Yang	Associate Director of Co-Operate Communication
Boon Chong Tan	Deputy General Manager
Edin Buljubasic	Vice President
Yingming Yue	Vice President
Valerie Lau	Chief Commercial Officer-APAC